Isabel Fabregat is Senior Investigator, head of the “TGF-β and Cancer” group at IDIBELL and part-time Associate Professor in the University of Barcelona. The current research line of her laboratory focuses on the dissection of the molecular mechanisms induced by Transforming Growth Factor-beta (TGF-β) in liver cells that can explain its different, and sometimes opposite,…
Read More
Elias Campo received his MD and PhD degrees from the Medical School at the University of Barcelona. He was a post-doctoral researcher at the Laboratory of Pathology, National Cancer Institute, Bethesda, MD. He is currently Professor of Pathology and Chief of the Hematopathology Unit at the Hospital Clinic of Barcelona, University of Barcelona. His research…
Read More
Anna Sureda, (MD, PhD) is nowadays the Head of the Clinical Hematology Department of Institut Català d’Oncologia – Hospitalet, Barcelona. She had previously been a senior consultant in Hospital de la Santa Creu I Sant Pau, Barcelona and a senior consultant focused in lymphomas and hematopoietic stem cell transplantation in Cambridge, UK. She was a…
Read More
René Bernards is a professor of molecular carcinogenesis at the Netherlands Cancer Institute. His laboratory uses functional genomic approaches to find vulnerabilities of cancers that can be exploited therapeutically. Using the concept of synthetic lethality, his laboratory searches for combinations of drugs that are lethal for cancer cells and for vulnerabilities of cancer cells of…
Read More
Cristina Muñoz Pinedo, leader of Cell Death Regulation Group at Oncobell will chair Targeting of Signaling Pathways table in the next Oncobell Symposium. Cristina Muñoz-Pinedo’s group researches the mechanisms through which tumour cells die in response to different treatments, and to glucose metabolism inhibition in particular. It studies the responses both at the cell level…
Read More
LECTURE: Oscar Martinez-Tirado is going to talk about "Understanding sarcomas: a path to a successful treatment" BIOGRAPHY: Oscar Martinez-Tirado is the leader of the Sarcoma Research Group at IDIBELL. His laboratory focuses on uncovering the biological mechanisms involved in the progression of developmental sarcomas and the discovery of new potential treatments that can improve the…
Read More
The aim of Dr Aytes’s group is to discover new mechanisms which lead to cancer progression and metastasis, and to clarify how these mechanisms contribute to the onset of treatment resistance. The group’s main focus is on prostate cancer, which is the second leading cause of cancer mortality among men. It uses genetically engineered mice…
Read More
LECTURE: Dr. Oriol Casanovas is going to talk about "Resistance to Antiangiogenic Therapies by Metabolic Escape via Nucleotide Catabolism" BIOGRAPHY: Dr. Oriol Casanovas is an internationally renowned laboratory researcher with ample knowledge and expertise in basic and translational research of mouse models of cancer and tumor angiogenesis. His research at ICO-IDIBELL in Barcelona has always been…
Read More
Miguel Ángel Pujana, leader of the Breast Cancer Group within Oncobell, presents the strategic lines, the current projects and the future objectives of his research.
Read More
Dr. Ramon Salazar, Oncobell's head coordinator of research, presents the first symposium "Mechanisms of Cancer and New Therapeutic Strategies" and the different research groups of the division. In collaboration with TERTULIAS ONCOLÓGICAS.
Read More